NEW YORK ( TheStreet) -- Jim Cramer likes the growth-oriented as well as the yield-oriented Big Pharma stocks, he told Nicole Urken, "Mad Money's" research associate, Monday. "The international investor who is looking for a home will want to find yield and will want to find safety."
'Mad Money' Uncovered: Big Pharma on a Down Day in the Market
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts